Search for:
Home
About Us
Therapeutic areas
Products
Tasectan® AF Adults & Kids
Tasectan® Duo Adults & Kids
Tasectan® Hydro
Utipro® Plus AF
Ulkox®
Partnering
Magazine
Partners Portal
Partners Portal
Search
Contact
Menu
Search for:
Home
About Us
Therapeutic areas
Products
Tasectan® AF Adults & Kids
Tasectan® Duo Adults & Kids
Tasectan® Hydro
Utipro® Plus AF
Ulkox®
Partnering
Magazine
Partners Portal
Contact
Gastroenterology
»
Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.
Gastroenterology
,
Scientific publication
,
XILAPLUS® AF
October 20, 2025
Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.
Lucio Gnessi, Xavier Llop, Núria Piqué.
23rd UEG WEEK BARCELONA. October 24-28 2015
Back to Magazine
Prev
Previous
Undissociated gelatine tannate and xyloglucan prevent gut leakiness and mucosal inflammation induced by LPS: insights in the mechanism of action.
Next
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.
Next
